Our Mission
The Metrics Champion Consortium (MCC) is an open, multidisciplinary, non-profit organization comprised of biotechnology, pharmaceutical and service provider organizations. The mission of MCC is to develop, through a collaborative process, Performance Metrics within the Biotechnology and Pharmaceutical industry with the intent to jointly encourage performance improvement, effectiveness, efficiency, and appropriate levels of controls for both Sponsors and Service Providers in support of the drug development process.
The MCC relies heavily on volunteers to make progress on its mission and strategic goals. However, there is a certain level of funding that is required for the administration of MCC functions and for providing facilitators with the appropriate expertise to lead and support the Working Groups. This funding is primarily provided through Corporate Sponsors and Members of MCC. Without financial support, MCC would have been unable to make the progress demonstrated over the past several years. Corporate memberships are contributions that are essential to the survival of the organization and the continued progress in developing worldwide industry standards to promote performance improvement of biotechnology, pharmaceutical, and service provider organizations.
Interested in more information? MCC Brochure [pdf] Membership fees [pdf] Membership Application Form MCC e-mail list
MCC News
MCC launched Clinical Trial Metrics Process Improvement Working Group contact Linda Sullivan for details.
MCC Clinical Trial Performance Metrics (Beta version) released for feedback April 2009 - Clinical Trial Performance Metrics v 1.0 to launch in 2010.
MCC ECG Metrics featured in European Pharmaceutcial Contractor article by Jeffrey Litwin, MD [click here to link to publisher website]
MCC featured in April issue of PharmaVoice [click here to view article]
MCC presenting at the IIR Central Labs West conference [click here to view meeting details] [MCC member discount code]
Thursday, February, 4, 2010
Track C: Oncology Case Studies and Therapeutic Area Round Tables
1:30pm – Implementation of Imaging Metrics to Monitor Oncology Studies
Natasha F. Homji, MS, Study Manager II, Oncology Imaging, NOVARTIS PHARMACEUTICALS
Friday, February 5, 2010
Plenary Session
8:30am - MCC LAB, ECG and Imaging Metrics Adoption, Implementation and Updates
Guy Mascaro, President, MCC
Julie DeBus-Levy, Manager, Outsourcing and Contracts, ABBOTT LABORATORIES
Pia Strannelind, Global Account Manager, Technology, ASTRAZENECA
Natasha F. Homji, MS, Study Manager II, Oncology Imaging, NOVARTIS PHARMACEUTICALS
Visit us in the Exhibit Hall at Booth #17
TWO MEETINGS ..... SAME LOCATION
See MCC Member Homepage for registration information
MCC presenting at the Lean Sigma & Kaizen for Life Sciences R&D conference [click here to view meeting details] [MCC member discount code]
MCC leading half-day workshop at the IIR Partnerships in Clinical Trials conference [click here to view meeting details] [MCC member discount code]
MCC presented at CBI's Inaugural Conference on Contracting for CROs • December 2 - 3 , 2009 • Philadelphia, PA click here for presentations ...
MCC presented at the ExL Pharma 5th Annual Clinical Performance Metrics & Benchmarking Summit click here for details...
MCC releases Imaging Performance Metrics version 1.0 click here for details ...
MCC launches ECG Metrics Sponsor Survey click here for details ...
ACRO Names Two CRO leaders to MCC Board of Directors [7.30.2008 press release]
MCC featured in Applied Clinical Trials article
Performance Metrics Initiative Updates: To learn more about a specific MCC metrics initiative and join a work group, please click on the icon:
